Treatment of cancer patients during the COVID-19 pandemic in the Philippines

COVID-19: Misinformation, medical literacy, and the coronavirus

Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from COVID-19

Economic and research benefits of the AORTIC meeting

Managing toxicities associated with immune-checkpoint inhibitors

Gynaecological cancers in the era of fertility preservation

I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer

Conducting Oncology Clinical Trials in Africa II: Strategies for Building Needed Research Infrastructure for Clinical Trials

COVID-19: Managing paediatric patients under the COVID pandemic

Conducting Oncology Clinical Trials in Africa II: Innovative recruitment methods for oncology clinical trials

Meet the Expert: Dr Bodour Salhia

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma